Vitamin D and Its Receptor Gene Polymorphisms in Lithuanian, Latvian and Taiwanese Patients With Atopic Dermatitis and Asthma
NCT ID: NCT04354207
Last Updated: 2020-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2020-01-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Vitamin D acts by binding to the vitamin D receptors (VDRs), which are located in a variety of tissues. VDRs have been identified on nearly all cells of the immune system including T cells, B cells, neutrophils, macrophages, and dendritic cells (DCs).
Vitamin D deficiency predisposes to gastrointestinal infections by changing gut micro-biota, which may promote the development of food allergy. However the detail mechanism how vitamin D affects or protects the development of allergic diseases is still unknown. Vitamin D level is determined by sun exposure.
Due to the fact that Lithuania, Latvia and Taiwan are located in different latitudes of north hemisphere with markedly different sun exposure, in this Joint collaboration study between Taiwan, Lithuanian and Latvia, we are going to study, (1). Serum vitamin D level in children and adults with AD and/or asthma in Lithuania, Latvia and Taiwan. (2). VDRs genetic polymorphisms of AD and/or asthma in children and adults in Lithuania, Latvia and Taiwan. (3). Finally, we would like to explore the gut microbiome of patients with AD and/or asthma in Lithuanian, Latvian and Taiwanese children and adults; and to estimate possible relationship between gut microbiome and vitamin D level and VDRs genetic polymorphisms. We believe that this study will be the first which compares the populations with different geographical and ecological factors having the same allergic diseases. We hope that these results will provide the answer about the role of vitamin D in the prevention, or in the future, in treatment of allergic diseases.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vit D to Treat Asthma in Children: a Randomized, Double-blind, Placebo-controlled Trial
NCT01284907
Vitamin D Deficiency and Asthma Exacerbation
NCT02661191
Vitamin D Supplementation in Childhood Atopic Dermatitis
NCT00879424
Vitamin D for the Treatment of Severe Asthma
NCT00712205
High-dose Vitamin D Supplement for the Prevention of Acute Asthma-like Symptoms in Preschool Children
NCT05043116
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Atopic dermatitis
Peripheral vein punction
Vitamin D level, vitamin D receptor genetic polymorphisms, allergen specific IgE and total IgE will be measured in peripheral blood
Stool collection
Gut microbiome will be investigated in stool samples.
Asthma
Peripheral vein punction
Vitamin D level, vitamin D receptor genetic polymorphisms, allergen specific IgE and total IgE will be measured in peripheral blood
Stool collection
Gut microbiome will be investigated in stool samples.
Healthy individuals
Peripheral vein punction
Vitamin D level, vitamin D receptor genetic polymorphisms, allergen specific IgE and total IgE will be measured in peripheral blood
Stool collection
Gut microbiome will be investigated in stool samples.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peripheral vein punction
Vitamin D level, vitamin D receptor genetic polymorphisms, allergen specific IgE and total IgE will be measured in peripheral blood
Stool collection
Gut microbiome will be investigated in stool samples.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with mild to moderate atopic dermatitis
* Healthy individuals
Exclusion Criteria
* Oncological diseases
* Acute systemic autoimmune diseases
* Use of systemic immunosuppressants (wait 1 month)
* Use of vitamin D supplementation
* Use of systemic antihistamines (wait 1 week)
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Research Council of Lithuania
OTHER
Lithuanian University of Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brigita Sitkauskiene
Prof., Head of Department of Immunology and Allergology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brigita Sitkauskiene, Prof.
Role: PRINCIPAL_INVESTIGATOR
Lithuanian University of Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital of Lithuanian University of Health Sciences Kauno klinikos
Kaunas, , Lithuania
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-LLT-20-1
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
LLTADA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.